GRAZIANI, GRAZIA

GRAZIANI, GRAZIA  

Dipartimento di Medicina dei sistemi  

Mostra records
Risultati 1 - 20 di 254 (tempo di esecuzione: 0.027 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2008 5(2-bromovinyl)-2’-deoxyuridine (BVDU), increases the amount of chromatid breaks induced by bleomycin in mismatch repair deficient tumor cells by inhibiting homologous recombination Vernole, P; Muzi, A; Graziani, G; Volpi, A Intervento a convegno
1-gen-2000 5-Fluorouracil increases carcinoembryonic antigen expression and shedding in colon cancer cell clones with different basal levels of the molecule Aquino, A; Prete, S; Guadagni, F; Greiner, J; Giuliani, A; Orlando, L; Masci, G; De Santis, S; Bonmassar, E; Graziani, G Intervento a convegno
1-gen-2002 A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report Aquino, A; Prete, S; Balduzzi, A; Fossile, E; Formica, V; Torino, F; Bonmassar, L; Di Giacomo, A; Cappelletti, D; Cardillo, A; Graziani, G Articolo su rivista
1-apr-1991 A region of proto-dbl essential for its transforming activity shows sequence similarity to a yeast cell cycle gene, CDC24, and the human breakpoint cluster gene, bcr Ron, D; Zannini, M; Lewis, M; Wickner, R; Hunt, L; Graziani, G; Tronick, S; Aaronson, S; Eva, A Articolo su rivista
1-gen-2016 Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D’Atri, S; Lacal, P Intervento a convegno
1-nov-1998 Adjuvant treatment of breast cancer: a pilot immunochemotherapy study with CMF, interleukin-2 and interferon alpha Tonini, G; Nunziata, C; Prete, S; Pepponi, R; Turriziani, M; Masci, G; Graziani, G; Bonmassar, E; DE VECCHIS, L Articolo su rivista
1-lug-1991 Alternative splicing generates at least five different isoforms of the human basic-FGF receptor Eisemann, A; Ahn, J; Graziani, G; Tronick, S; Ron, D Articolo su rivista
1-gen-2018 The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo. Atzori, Mg; Tentori, L; Ruffini, S; Ceci, C; Bonanno, E; Scimeca, M; Lacal, P; Graziani, G Articolo su rivista
1-gen-2017 The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells Atzori, Mg; Tentori, L; Ruffini, F; Ceci, C; Lisi, L; Bonanno, E; Scimeca, M; Eskilsson, E; Daubon, T; Miletic, H; Ricci Vitiani, L; Pallini, R; Navarra, P; Bjerkvig, R; D'Atri, S; Lacal, Pm; Graziani, G Articolo su rivista
1-gen-2022 Antibody-drug conjugates: resurgent anticancer agents with multi-targeted therapeutic potential Ceci, C; Lacal, Pm; Graziani, G Articolo su rivista
1-gen-1985 Antigenic changes induced in tumor cells in vivo by dimethil-imidazole carboxamide (DTIC) Fioretti, M; Romani, L; Giuliani, A; Puccetti, P; Guadagni, F; Graziani, G; Tricarico, M; Bonmassar, E Intervento a convegno
1-gen-2016 Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D'Atri, S; Lacal, P Articolo su rivista
1-gen-2000 Apoptotic and clastogenic effects of methylating agents, alone or combined with poly(ADP-ribose) polymerase inhibitor, in peripheral blood lymphocytes Tentori, L; Vernole, P; Portarena, I; Bonmassar, E; Graziani, G Intervento a convegno
1-gen-2002 Apoptotic and genotoxic effects of a methyl sulfonate ester that selectively generates N3-methyladenine and poly(ADP-ribose) polymerase inhibitors in normal peripheral blood lymphocytes Tentori, L; Portarena, I; Vernole, P; Gold, B; Graziani, G Articolo su rivista
1-gen-2020 Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2 Lisi, L; Lacal, P; Barbaccia, M; Graziani, G Articolo su rivista
1-gen-2021 At the cutting edge against cancer: A perspective on immunoproteasome and immune checkpoints modulation as a potential therapeutic intervention Tundo, Gr; Sbardella, D; Oddone, F; Kudriaeva, Aa; Lacal, Pm; Belogurov, Aa; Graziani, G; Marini, S Articolo su rivista
1-ago-2000 Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells D'Atri, S; Graziani, G; Lacal, P; Nisticò, V; Gilberti, S; Faraoni, I; Watson, A; Bonmassar, E; Margison, G Articolo su rivista
1-feb-2001 Bacillus Calmette-Guerin down-regulates CD1b induction by granulocyte-macrophage colony stimulating factor in human peripheral blood monocytes Prete, S; Giuliani, A; Iona, E; Fattorini, L; Orefici, G; Franzese, O; Bonmassar, E; Graziani, G Articolo su rivista
1-gen-2007 BCG-infected adherent mononuclear cells release cytokines that regulate group 1 CD1 molecule expression Prete, Sp; Giuliani, A; D'Atri, S; Graziani, G; Balduzzi, A; Oggioni, Mr; Iona, E; Girolomoni, G; Bonmassar, L; Romani, L; Franzese, O Articolo su rivista
13-mar-2018 Beneficial and Detrimental Effects of Antiretroviral Therapy on HIV-Associated Immunosenescence Franzese, O; Barbaccia, Ml; Bonmassar, E; Graziani, G Articolo su rivista